ABVC Stock Analysis: Buy, Sell, or Hold?
ABVC - ABVC BioPharma, Inc. Common Stock
$1.27
0.08 (6.72%)
▲
5d:
-5.22%
30d:
+17.59%
90d:
-3.79%
HOLD
LOW Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: May 20, 2026
0d
Get Alerted When ABVC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ABVC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ABVC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ABVC is currently trading at $1.27, which is considered fair relative to its 30-day fair value range of $1.09 to $1.35.
Technical Outlook: Technically, ABVC is in a strong downtrend. Immediate support is located at $1.19, while resistance sits at $1.48. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.02 (+69.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ABVC is in a strong downtrend. Immediate support is located at $1.19, while resistance sits at $1.48. The stock is showing strong short-term momentum, up 6.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.02 (+69.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.09 -
$1.35
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.7%)
- BULLISH: Trading 69.7% below Wall St target ($2.02)
- CAUTION: Recommendation downgraded due to -5.2% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.09 -
$1.35
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.19
Resistance Level
$1.48
Current Trend
Strong Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Wall Street Target
$2.02
(+69.7%)
Revenue Growth (YoY)
104.5%
Share & Embed Analysis
Last updated: June 15, 2026 9:52 AM ET
Data refreshes hourly during market hours. Next update: 10:52 AM
Data refreshes hourly during market hours. Next update: 10:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABVC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 62 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 58 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 60 HOLD |
